10th Annual Conference on the Science of Dissemination and Implementation
|
Meeting/ Workshop
|
AHRQ
|
NCCIH, NCI, NHLBI, NIAAA, NIAID, NIDA, NIDDK, NIMH, NINR
|
2014
|
|
2016 NCI SBIR Workshop on Facilitating the Development of Molecularly Targeted Radiotherapy
|
Training Initiative
|
FDA
|
NCI
|
2017
|
|
2018 Physical Activity Guidelines Advisory Committee Report
|
Committee, Advisory Group, or Work Group
|
CDC
|
NCI, OD/ DPCPSI/ ODP
|
1997
|
|
A Pilot Study of Urinary Carcinogen Biomarkers in the Golestan Cohort Study
|
Research Initiative
|
CDC, FDA
|
NCI
|
2015
|
|
A Study of Markers of Cosmic Radiation Exposure and Effect Among Flight Crews
|
Research Initiative
|
CDC
|
NCI
|
1998
|
|
A Working Group to Consider the Question of Federal Public Health and Medical Resource Allocation
|
Committee, Advisory Group, or Work Group
|
OS
|
CC
|
2011
|
|
A5349/TBTC S31 - Rifapentine - Containing Treatment Shortening Regimens for Pulmonary Tuberculosis: A Randomized, Open-Label, Controlled Phase 3 Clinical Trial
|
Research Initiative
|
CDC
|
NIAID
|
2015
|
|
Abuse Liability Evaluation for Research, Treatment, and Training (ALERTT)
|
Research Initiative
|
FDA
|
NIDA
|
2011
|
|
Accelerating Medicines Partnership
|
Other
|
FDA
|
NIA, NIAMS, NIDDK, NINDS, OD/ OSP
|
2014
|
|
AccessGUDID
|
Resource Development
|
FDA
|
NLM
|
2015
|
|
Action for Health in Diabetes (Look AHEAD)
|
Research Initiative
|
CDC, IHS
|
NIA, NIDDK
|
1999
|
|
Adjuvant Working Group
|
Committee, Advisory Group, or Work Group
|
BARDA, FDA
|
NCI, NIAID
|
2013
|
|
Administrative Supplements on HIV Pre-Exposure Prophylaxis Implementation Science in CDC-Funded Public Health Demonstration Projects
|
Research Initiative
|
CDC
|
NIMH
|
2016
|
|
Adolescent Brain Cognitive Development (ABCD) Study
|
Research Initiative
|
CDC
|
NCI, NIAAA, NICHD, NIDA, NIMH, NIMHD, NINDS, OD/ DPCPSI/ OBSSR
|
2016
|
|
Adolescent HIV Prevention and Treatment Implementation Science Alliance (AHISA)
|
Committee, Advisory Group, or Work Group
|
CDC
|
FIC, NIAID, NICHD, NIMH, OD/ DPCPSI/ OAR
|
2016
|
|
Advanced Anticonvulsant System Interagency Product Team
|
Committee, Advisory Group, or Work Group
|
FDA, OS
|
NINDS
|
2011
|
|
Adverse Event Reporting and Medical Countermeasures
|
Resource Development
|
FDA
|
NLM
|
2013
|
|
Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
|
Committee, Advisory Group, or Work Group
|
CDC, FDA, OS
|
CC, NHLBI
|
2003
|
|
Advisory Committee on Heritable Disorders in Newborn and Children
|
Committee, Advisory Group, or Work Group
|
AHRQ, CDC, FDA, HRSA
|
NICHD
|
2014
|
|
Advisory Committee on Organ Transplantation (ACOT)
|
Committee, Advisory Group, or Work Group
|
HRSA
|
NIAID
|
2009
|
|
AHRQ - Systematic Evidence Reviews
|
Other
|
AHRQ
|
NHLBI
|
2015
|
|
AHRQ evidence report on Comparative Effectiveness of Interventions to Manage Labor and AHRQ evidence report on Labor Dystocia
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NICHD
|
2017
|
|
AHRQ National Guidelines Clearinghouse/National Quality Measures Clearinghouse (NQMC/NGC) Editorial Board
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NLM
|
2013
|
|
AHRQ Patient Safety Workgroup
|
Committee, Advisory Group, or Work Group
|
AHRQ
|
NLM
|
2005
|
|
AHRQ Registry of Patient Registries (RoPR)
|
Resource Development
|
AHRQ
|
NLM
|
2013
|
|